digestive-diseases-2016_scientifictracks-abstracts

Volume 6, Issue 8(Suppl)

J Gastrointest Dig Syst 2016

ISSN:2161-069X JGDS, an open access journal

Page 43

Notes:

Digestive Diseases 2016

December 08-09, 2016

conferenceseries

.com

Digestive Diseases

December 08-09, 2016 Dubai, UAE

International Conference on

Primary endoscopic therapies for obesity and metabolic disease

Mahmoud Saad Berengy

Al-Azhar University, Egypt

Purpose:

Endoscopic approaches to obesity may help fulfill the unmet need of over half the most adult population who would

benefit from therapy for obesity but are not receiving it. Endoluminal approaches have the potential to be more efficacious than

anti-obesity medications and have a lower risk-cost profile compared with bariatric surgery. This session outlines the current state of

primary endoscopic weight loss and metabolic therapies and sheds light on the challenges faced towards making endoscopic bariatric

therapies 'ready for prime time'.

Recent Findings:

Endoscopic approaches to obesity are being increasingly modeled on the proposed mechanisms contributing to

the benefits of bariatric surgery. Therapies targeted at the stomach induce weight loss with only a proportional benefit to underlying

metabolic disorders.Therapies targeting the proximal small bowel appear to modulate various neuro-hormonal pathways resulting in

an improvement in metabolic profile in excess to that accounted for by weight-loss itself.

Summary:

Rigorous scientific assessment of endoscopic approaches to obesity is necessary to allow its integration into the treatment

algorithm of obesity. The endoscopic armamentarium against obesity continues to evolve with the Endoscopist poised to be a key

player in the management of this disease.

Biography

Mahmoud SaadBerengy is currently working in Al-Azhar University, Egypt

Mahmoud Saad Berengy, J Gastrointest Dig Syst 2016, 6:8(Suppl)